相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?
Angela Jornada Ben et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)
Linear mixed models to handle missing at random data in trial-based economic evaluations
Andrea Gabrio et al.
HEALTH ECONOMICS (2022)
A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis
Xiaoxiao Ling et al.
VALUE IN HEALTH (2022)
A scoping review of statistical methods for trial-based economic evaluations: The current state of play
Mohamed El Alili et al.
HEALTH ECONOMICS (2022)
What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?
Johanna M. van Dongen et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)
Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis
Baptiste Leurent et al.
HEALTH ECONOMICS (2020)
Taking the Analysis of Trial-Based Economic Evaluations to the Next Level: The Importance of Accounting for Clustering
Mohamed El Alili et al.
PHARMACOECONOMICS (2020)
Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data
Jaap Brand et al.
STATISTICS IN MEDICINE (2019)
Reporting of Multi-Arm Parallel-Group Randomized Trials Extension of the CONSORT 2010 Statement
Edmund Juszczak et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A full Bayesian model to handle structural ones and missingness in economic evaluations from individual-level data
Andrea Gabrio et al.
STATISTICS IN MEDICINE (2019)
Methods for estimating complier average causal effects for cost-effectiveness analysis
K. DiazOrdaz et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2018)
Bootstrap inference when using multiple imputation
Michael Schomaker et al.
STATISTICS IN MEDICINE (2018)
Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology
Mohamed El Alili et al.
PHARMACOECONOMICS (2017)
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
Andrea Gabrio et al.
PHARMACOECONOMICS-OPEN (2017)
Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches
Dyfrig Hughes et al.
PHARMACOECONOMICS (2016)
Multiple imputation strategies for zero-inflated cost data in economic evaluations: which method works best?
Janet MacNeil Vroomen et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
Cost-Effectiveness Analysis Alongside Clinical Trials II-An ISPOR Good Research Practices Task Force Report
Scott D. Ramsey et al.
VALUE IN HEALTH (2015)
mice: Multivariate Imputation by Chained Equations inR
Stef van Buuren et al.
Journal of Statistical Software (2015)
Advantages of the Net Benefit Regression Framework for Economic Evaluations of Interventions in the Workplace A Case Study of the Cost-Effectiveness of a Collaborative Mental Health Care Program for People Receiving Short-Term Disability Benefits for Psychiatric Disorders
Jeffrey S. Hoch et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2014)
A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
Rita Faria et al.
PHARMACOECONOMICS (2014)
Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis
Jos Twisk et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Review of inverse probability weighting for dealing with missing data
Shaun R. Seaman et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Developing Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized Trials
Manuel Gomes et al.
MEDICAL DECISION MAKING (2012)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Stavros Petrou et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Health outcomes in economic evaluation: the QALY and utilities
Sarah J. Whitehead et al.
BRITISH MEDICAL BULLETIN (2010)
NON-PARAMETRIC METHODS FOR COST-EFFECTIVENESS ANALYSIS: THE CENTRAL LIMIT THEOREM AND THE BOOTSTRAP COMPARED
Richard M. Nixon et al.
HEALTH ECONOMICS (2010)
How to Deal with Cost Differences at Baseline
Antoinette D. I. van Asselt et al.
PHARMACOECONOMICS (2009)
Assessing the impact of censoring of costs and effects on health-care decision-making: An example using the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study
Elisabeth Fenwick et al.
VALUE IN HEALTH (2008)
Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
Andrea Burton et al.
CLINICAL TRIALS (2007)
Cost-effectiveness analyses alongside randomised clinical trials
Alastair M. Gray
CLINICAL TRIALS (2006)
Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations
RM Nixon et al.
HEALTH ECONOMICS (2005)
How sensitive are cost-effectiveness analyses to choice of parametric distributions?
SG Thompson et al.
MEDICAL DECISION MAKING (2005)
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility
A Manca et al.
HEALTH ECONOMICS (2005)
Parametric modelling of cost data: some simulation evidence
A Briggs et al.
HEALTH ECONOMICS (2005)
Regression methods for cost-effectiveness analysis with censored data
AR Willan et al.
STATISTICS IN MEDICINE (2005)
Collection of health-economic data alongside clinical trials: Is there a future for piggyback evaluations?
AK O'Sullivan et al.
VALUE IN HEALTH (2005)
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data
AR Willan et al.
HEALTH ECONOMICS (2004)
Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies
N Zethraeus et al.
PHARMACOECONOMICS (2003)